The complexities of hypertension: One disease or many?

Ann Marie Navar; Eric Peterson

doi:10.1001/jamacardio.2016.5676

The complexities of hypertension: One disease or many?

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	389-390
Number of pages	2
Journal	JAMA Cardiology
Volume	2
Issue number	4
DOIs	https://doi.org/10.1001/jamacardio.2016.5676
State	Published - Apr 2017
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2016.5676

Cite this

@article{f80ca1dfc29447d68e0c46ccea328a7f,

title = "The complexities of hypertension: One disease or many?",

author = "Navar, {Ann Marie} and Eric Peterson",

note = "Funding Information: completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Navar receives research support to her institution from Amgen, Sanofi, and Regeneron Pharmaceuticals, as well as consulting fees from Sanofi, outside the scope of this work. Dr Peterson receives consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Janssen, Merck, Regeneron, Sanofi, and Valeant and research support from Janssen, outside the scope of this work.",

year = "2017",

month = apr,

doi = "10.1001/jamacardio.2016.5676",

language = "English (US)",

volume = "2",

pages = "389--390",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - The complexities of hypertension

T2 - One disease or many?

AU - Navar, Ann Marie

AU - Peterson, Eric

N1 - Funding Information: completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Navar receives research support to her institution from Amgen, Sanofi, and Regeneron Pharmaceuticals, as well as consulting fees from Sanofi, outside the scope of this work. Dr Peterson receives consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Janssen, Merck, Regeneron, Sanofi, and Valeant and research support from Janssen, outside the scope of this work.

PY - 2017/4

Y1 - 2017/4

UR - http://www.scopus.com/inward/record.url?scp=85031421414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031421414&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2016.5676

DO - 10.1001/jamacardio.2016.5676

M3 - Comment/debate

C2 - 28199465

AN - SCOPUS:85031421414

SN - 2380-6583

VL - 2

SP - 389

EP - 390

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 4

ER -

The complexities of hypertension: One disease or many?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this